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Abstract
Background: Antimicrobial resistance is an increasing problem in developing countries and antibiotic use is
widespread. Our previous surveys in Java, Indonesia, revealed that most antibiotic use was probably unnecessary or
ineffective. The aim of this study was to explore a potential connection between resistance and substandard
antibiotics sold in the area.
Methods: A cross-sectional field study using the simulated client method was conducted in Surabaya. Five first-line
antibiotics were requested with or without prescription (OTC). A certified laboratory analysed the drug content
using validated methods. Possible determinants of substandard quality were explored.
Results: In total, 104 samples from 75 pharmacies, ten drug stores and 39 roadside stalls (kiosks) were obtained.
Pharmacy employees filled all OTC requests. Three quarters of kiosks sold antibiotics. Antibiotics were dispensed as
single blister strips or repackaged (16%) without label. Ninety five percent of samples carried the label of 14
Indonesian manufacturers. The pharmaceutical quality did not meet BP standards for 18% of samples. Deviations
(less active ingredient) were small. There was no association between low content and type of outlet, sold with or
without prescription, registration type, price or packaging. Median retail prices of products carrying the same label
varied up to 20 fold.
Conclusions: Antibiotics were available OTC in all visited pharmacies and sold in the streets of an Indonesian city.
Most samples contained an active ingredient. We urge to increase enforcement of existing regulations, including
legislation that categorizes antibiotics as prescription-only drugs for all types of medicine outlets, to limit further
selection of antimicrobial resistance.
Background
Antimicrobial resistance is an increasing global crisis in
developing countries. Antibiotic use, particularly over
the counter, is widespread. Very little data substantiate
this problem. We surveyed antibiotic usage and resis-
tance in two areas on Java, Indonesia [1] in individuals
who visited public healthcare facilities. Those who could
cite the name and dosing regimens of antibiotics had
consumed short courses (median three days) of
amoxicillin or ampicillin, chloramphenicol, ciprofloxacin,
cotrimoxazole, and tetracycline. The antibiotics were
prescribed by doctors in public hospitals (12%), health-
care centers (29%), private practice (36%), and by nurses
and midwives (6%). Similar antibiotics were self-medi-
cated by 17% of the individuals. Antibiotics were pur-
chased from community pharmacies, drug stores,
traditional Chinese medicine prescribers (shinshes) or
their shops and kiosks (roadside stalls, usually on
wheels) in the areas surrounding the healthcare facilities.
Low dosage regimens were reported [2]. Among 3275
individuals (community 2494, hospital 781), 54% carried
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any medium, provided the original work is properly cited.resistant Escherichia coli. Recent antibiotic use was the
most important determinant of resistance in both popu-
lations [community: odds ratio (OR) 1.8, 95% confidence
interval (95% CI) 1.5-2.3; hospital: OR 2.5, 95% CI 1.6-
3.9] [3]. We hypothesized that the low-dose regimens of
a limited number of classes could have contributed to
the development of resistance. In addition, if antibiotics
o nt h em a r k e ti nt h i sa r e ah a v eal o wc o n t e n t ,t h i s
would further expose bacteria to low concentrations and
select for resistance in this population. If, on the other
hand, some products are counterfeit and contain no
antibiotic at all, the conclusions of our studies of the
association between use and resistance in the area
would be invalid.
Substandard and counterfeit anti-infective drugs can
cause therapy failure because of low dosage or absence
of active drug, adverse effects through excessive dose or
the presence of incorrect or toxic ingredients, and emer-
gence of antimicrobial resistance through subtherapeutic
amounts of the antimicrobial drugs [4]. A substandard
drug is a drug that fails to meet the specifications upon
laboratory testing in accordance with the specifications
it claims to comply with. Drugs can be substandard
among others because they are produced with low qual-
ity or chemically instable ingredients or stored in inade-
quate conditions. According to the WHO definition, a
counterfeit drug is one that is deliberately and fraudu-
lently mislabeled with respect to identity, source, or
both [5,6]. Counterfeit products can contain the correct
amount, too little or too much of the active ingredient.
Packaging can provide clues about counterfeiting [7].
The problem of substandard and counterfeit drugs is
particularly prevalent in low-income and developing
countries. Insufficient regulation and manufacturing
control are major causes [5]. In the last decade, substan-
dard anti-malarial, antibacterial, and antiviral drugs have
been reported in South East Asia [8-10]. There are
plenty of reviews and reflection papers [11-13], but
recent reliable data on the prevalence of substandard
drugs are lacking [14]. Recently, experts called for more
political will and less secrecy and for reporting of the
manufacturer’s name as stated on the packaging [4].
There are very few publications on the quality of anti-
infective drugs on the market in Indonesia [15,16]. As is
c o m m o ni nm a n yl o w - i n c o m ec o u n t r i e s ,d r u g sa r ep u r -
chased in private drug outlets. Silverman et al. and Lee
et al. stated in 1990 [15] and 1991[17], respectively, that
in Indonesia, fraudulent drug products may represent
20-30% of all drug products on the market. However,
no methodological details were provided. The Indone-
sian Drug and Food Control Agency (BPOM) reported
that antibiotics are amongst the most commonly coun-
terfeited drugs. In 2003, BPOM discovered 55 counter-
feit medicines being sold in the market. Among them
were amoxicillin 500 mg capsules that contained only
45.84% of the active ingredient [18]. Drug legislation
and regulation have improved in Indonesia. In 2003 the
government updated regulations regarding good manu-
facturing practice for the many local private and state
companies that produce medicines, mostly generics [19].
The law categorizes antibiotics as prescription-only
drugs to be retailed in pharmacies only [20]. Pharmacies
and drug stores need a government license. Pharmacies
are allowed to sell all categories of drugs. Drug stores
have a limited license and are not allowed to dispense
prescription-only drugs and narcotics. Kiosks can only
sell “free drugs”, e.g. vitamins and paracetamol. The
strategic report Indonesia Pharmaceutical and Health-
care Report Q3 2006 and the Matrix of Drug Quality
Report (update 2008) mentioned that fake products
accounted for up to 20-25% of total drug sales [18,21].
One method to study medicine dispensing is to use
simulated clients, a method widely practiced by both
consumer organisations and researchers [22]. We choose
this method to obtain independent and unbiased infor-
mation on availability and quality of drugs in our
setting.
In this paper we address the following two questions:
To what extent are first-line antibiotics available with or
without prescription in Indonesia, and secondly: what is
the pharmaceutical quality of the active ingredients
obtained in these ways?
Methods
Study design
A cross sectional survey of potential retailers of antibio-
tics was conducted within the framework of the AMRIN
Study [1-3]. The protocol of the AMRIN study was
approved by the Dr. Soetomo Hospital ethics committee
(ethical clearance No.5/Panke.KKE/2001 (Surabaya). The
s t u d ya r e aw a st h ec i t yo fS u r a b a y a ,E a s tJ a v a ,i nt h e
streets surrounding the government hospital and two
public health centres that had participated in our pre-
vious [2] antibiotic survey.I nt h i ss u r v e y ,4 1 7u s e r so f
antibiotics cited community pharmacies drug stores, tra-
ditional Chinese medicine prescribers (shinshes) or their
shops and kiosks (roadside stalls, usually on wheels) as
providers of the antibiotics that they used. The typical
profile of the OTC user was adult, male and without
health care insurance. Therefore, four volunteers (three
men and one woman) were trained to act as clients pur-
chasing antibiotics in these types of outlets. They
requested the first-line antibiotics with (pharmacy only)
or without prescription (all outlets) by the generic
name, as is the custom in Indonesia. Prescriptions for
three-day courses were made by a physician for the pur-
pose of the study and presented by the clients in phar-
macies only. Unfilled prescriptions were destroyed.
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standard symptoms of infection, e.g. fever, cough, pain
while passing urine, etc.
Sample collection
No reliable list of registeredp h a r m a c i e s ,d r u g s t o r e so r
kiosks of the city of Surabaya was available to us at the
time of the survey. A field sampling schedule was
d e s i g n e d( F i g u r e s1 a ,b ,c ) .S t a r t i n gf r o mt h eg o v e r n -
ment hospital and two public health centres that were
included in the previous survey [2], the four ‘clients’ had
to follow a distinct direction (north, west, south, and
east) and visit each consecutive retailer on the way.
Each retailer was visited once. A first sample size of 100
purchases was deemed appropriate as a pilot, consisting
of 20 samples of the most used five first-line antibiotics
(amoxicillin, chloramphenicol, tetracycline, cotrimoxa-
zole, or ciprofloxacin) each, with or without a prescrip-
tion. If large differences in content were found, the plan
w o u l db et oi n c r e a s et h es a m p l es i z e .T h ef o l l o w i n g
information was recorded: date of purchase; name and
address of retailer; type of retailer; obtained with or
without prescription; storage conditions of the antibio-
tic; type of packaging; delivered with or without infor-
mation leaflet (package insert) or oral instruction, and
price. After the survey, a list of registered pharmacies
per district obtained from a local pharmaceutical com-
pany was used to estimate the coverage of our survey.
Figure 1 Study plan and actual sample collection of antibiotics from medicine outlets in areas surrounding public healthcare facilities
by simulated clients in the city of Surabaya. 1a Itineraries in the area surrounding the public hospital Dr. Soetomo. 1b Itineraries in the area
surrounding the public healthcare centre Puskesmas Pucang Sewu. 1c Itineraries in the area surrounding the public healthcare centre Puskesmas
Mojo.
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Samples were digitally photographed (camera Nikon
E7900, 3072 × 2304), including package and information
leaflet, when available. All samples were used for analysis.
Assays of tablets and capsules were performed by Farma-
lyse BV (Zaandam, the Netherlands), an ISO 9001: 2000
certified laboratory registered in the European Union as a
pharmaceutical control laboratory for chemical physical
analyses by license nr 101037. High performance liquid
chromatography (HPLC) (Thermo Electro Scientific,
Breda, The Netherlands) was used. The tests were per-
formed in duplicate and executed in conformity with
GMP-GCLP guidelines (Annex 14 + 15 GMP guidelines).
A separate quality assurance unit reviewed the final
report. For content of active ingredient assays of cotri-
moxazole, tetracycline, and chloramphenicol the British
Pharmacopoeia BP2005 monographs and standards were
used [23], for ciprofloxacin and amoxicillin the United
States Pharmacopeia USP 29 [24].
Statistical analysis
SPSS for Windows version 13 was used for all analyses.
Fisher’s exact test was used to analyze the association
between substandard quality (using BP limits) [23] and
retailer, storage conditions, packaging, stated manufac-
turer, whether the product was registered as generic or
branded, sold with or without prescription and price (>
20% above price set by the government). Prices in phar-
macies and kiosks and of generic and branded products
were compared by the Wilcoxon signed-rank test.
Results
Medicine outlets and availability of antibiotics
Between 7 and 15 April 2006, the four ‘clients’ requested
an antibiotic from the potential medicine retailers in the
city of Surabaya along the 3 × 4 routes of the study
plan. Figure 1a shows the yield on first route, departing
from the hospital. Details on the second and third route
are shown in Figure 1b and 1c. Only one of the first ten
drug stores and none of the four shinshes/traditional
Chinese medicine shops encountered sold antibiotics.
From that moment, samples primarily planned to be
purchased in drug stores or from shinshes were
requested without prescription in kiosks or pharmacies.
According to the list of the licensed community phar-
macies provided by the pharmaceutical company, the
study sample covered 3-57% of 12 of 31 sub-districts in
Surabaya. Overall, 12% of the 655 licensed pharmacies
in Surabaya were visited. All but one was a private phar-
macy and all had air conditioning. Total numbers of
drug stores, shinshes and kiosks in Surabaya were not
available, making it impossible to calculate the propor-
tion sampled for these retailers. In pharmacies, the
requested amount of product was dispensed from boxes
(blisters) or bottles of 500 to 1000 units. All antibiotics
and quantities were available, except for one pharmacy
that dispensed only 17 capsules of chloramphenicol
instead of 20. In kiosks, the antibiotics were exposed to
sunlight, average high Indonesian temperatures of 32°C
and high humidity. In six kiosks the requested number
of units was not available (four to seven instead of ten
units). Ten kiosks out of 39 did not sell antibiotics.
Antibiotic samples and dispensing
In Table 1 the characteristics of the purchased antibio-
tics are shown. All samples with prescription were
acquired from pharmacies. In case of a prescription,
pharmacy employees copied dose regimens from the
prescriptions onto a slip of paper and attached it to the
package. No information leaflets or oral instruction were
given. In case of purchase without prescription, the cli-
ents were never questioned or referred to a physician.
Both in pharmacies and kiosks, products with similar
appearance and packaging (according to visual inspec-
tion and comparison of the high resolution digital
photographs) were dispensed. Figure 2 shows a blister
strip of amoxicillin sold in a kiosk. Most samples were
generic products. Twenty-two percent of chlorampheni-
col, 15% of cotrimoxazole, and 60% of tetracycline sam-
ples were branded generics. Capsules were repackaged
in small plastic bags, 16% of which did not have a label
with the drug name or unit dose. For 95% of the sam-
ples, the tablets and capsules carried the labels of 14
Indonesian manufacturers (Table 2).
Content assay and analysis
Antibiotic samples were collected and stored in an air-
conditioned room until transportation for analysis to the
Netherlands in the third week of April 2006. According
to the BP2005 criteria, one fifth of amoxicillin tablets
and 5 of 22 tetracycline capsules samples contained
slightly less active substance than required (Table 3).
Fifty percent of cotrimoxazole tablets had a trimetho-
prim content which was not meeting BP standards;
deviations were up to 20% of the required amount.
None of the samples had excess active ingredient. No
association between low content and type of outlet (p =
0.58), sold with or without prescription (p = 0.78),
packaging (p = 0.8) registration type (generic versus
branded) (p = 0.54) or price (p = 0.33) was observed.
Substandard antibiotics carried the labels of six manu-
facturers (Table 2). On six out of ten substandard pro-
ducts a legible expiry date was printed on the blister
package, in all cases beyond January 2008.
Retail prices
In Table 4 a retail price comparison is given, including
the price set by the government [25]. Generic products
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chloramphenicol, cotrimoxazole, and tetracycline the
differences were statistically significant. In kiosks, retail
prices were significantly hi g h e rt h a ni np h a r m a c i e s .I n
pharmacies, there was no association between retail
price and lack of a prescription (data not shown).
Discussion
This field study showed that, despite existing regula-
tions, five first-line antibiotics could easily be obtained
without a prescription from medicine retailers in one of
the major cities in Indonesia. These antibiotics were
available in all community pharmacies visited. All phar-
macies and three quarters of roadside stalls sold antibio-
tics OTC, suggesting that the problem is widespread.
Apart from cotrimoxazole, most samples showed the
expected amounts of active ingredient.
The availability of antibiotics in other medicine out-
lets, that are not licensed for prescription-only drugs,
differed. Drug stores hardly retailed any antibiotics. This
was confirmed by a repeat visit to a few drug stores in
2007 (data not given). Former actions by the national
Figure 2 Antibiotic sample in a kiosk (roadside stall) in a street of Surabaya. Photograph by Usman Hadi.
Table 1 Characteristics of antibiotic products purchased by simulated clients at medicine outlets in Surabaya,
Indonesia
Antibiotic
samples
Amoxicillin
500 mg
(10 tablets)
N=2 0
Chloramphenicol
250 mg
(20 caps.
c)
N=2 3
Ciprofloxacin
500 mg
(10 tablets)
N=1 9
Co-
trimoxazole
480 mg
(10 tablets)
N= 20
Tetracycline
250 mg
(10 caps.)
N=1 9
Tetracycline
500 mg
(10 caps.)
N=3
Total
N = 104
Medicine outlet
pharmacy/kiosk/drug store 9/11/0 19/4/0 17/2/0 20/0/0 8/10/1 2/1/0 75/28/1
Prescription
yes/no 5/15 5/18 5/14 6/14 4/15 1/2 25/79
Packaging
blister/plastic bag 20/0 14/9 19/0 20/0 12/7 2/1 87/17
Registration
generic/branded generic 20/0 18/5 19/0 17/3 7/12 2/1 83/21
Price
a/sample
range 290-5000 150-1000 400-8000 145-870 138-1000 300-750 138-8000
median (IQR)
b 500 (313-700) 325 (250-500) 850 (500-850) 223 (200-405) 800 (150-900) 400(300-750) 500 (250-800)
aIn rupiah,
bInterquartile range,
cone pharmacy dispensed 17 capsules
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might have been effective. Distribution and sales of illeg-
ally imported drugs is punishable by up to five years of
imprisonment and a fine of two billion rupiah (around
140,000 EUR).
One of the reasons for OTC retailing in kiosks could
be that, having no fixed address, kiosk owners escape
control. Although there is no medical need for kiosks to
retail antibiotics for the purpose of availability - for
emergencies 24-hour coverage is given by hospital phar-
macies-, it is clear that kiosks fill a commercial demand.
Kiosks are convenient because they are numerous in
urban areas, easily accessible and pose no privacy pro-
b l e m sf o rt h en i g h t l yc l i e n tw i t he . g .as e x u a l l yt r a n s -
mitted disease. Tetracyclines are the most frequently
obtained antibiotics OTC [2]. Consumers may not be
Table 2 Stated manufacturer (city of residence) on blisters and/or logos for 104 samples and substandard content
assay result
Substandard assay test results/total Total
Stated to be manufactured by (city) Amoxicillin Chloramphenicol Ciprofloxacin Cotrimoxazole Tetracycline
Aditama Raya Farmindo (Surabaya) - - - 1/1 - 1/1
Bernofarm (Sidoarjo) - - 0/3 - - 0/3
Darya Varia Laboratoria (Bogor) - - - - 3/11 3/11
Dexa Medica (Palembang) - - 0/10 - - 0/10
Dumex (Jakarta
a) - - - - 1/1 1/1
ERBA/Kalbe Farma (Bekasi
a) - 0/2 - - - 0/2
First Meditama (Sidoarjo) - - - 0/1 - 0/1
Indofarma (Bekasi) 1/4 0/10 0/2 8/9 0/3 10/28
Kimia Farma (Jakarta) 0/1 0/2 0/1 0/3 0/2 0/9
Landson PT Pertiwi Agung (Jakarta
a) - 0/1 - - - 0/1
Phapros (Semarang) 2/14 - - 0/1 0/2 2/17
Saka Farma (Jakarta
a) - 0/2 - 0/1 - 0/3
Sanbe Farma (Bandung) - 0/4 0/3 0/3 - 0/10
Yarindo (Serang) 1/1 - - 1/1 - 2/2
Unknown - 0/2
b - - 1/3
c 1/5
Total 4/20 0/23 0/19 10/20 5/22 19/104
aHead office address,
bIn small plastic bags and no text or logo on white/green capsules,
cIn plastic bags and no text or logo on red and black caps.; red and
black caps. “BMF"; yellow and blue capsules “TETRA 500”
Table 3 Antibiotic content of 104 oral samples purchased in medicine outlets in Surabaya, Indonesia
Antibiotic Required active substance (%, min, max) Number of samples Content of active substance
mg (% of stated dosage)/
tablet or capsule
Content too low
a
Pharmacy Kiosk/Drug store Min Max N (%)
Amoxicillin
500 mg tablet
92.5 - 110 9 11 457 (91.4) 481 (96.2) 4 (25)
b
Chloramphenicol
250 mg capsule
95 - 105 19 4 239 (95.6) 260 (104) 0
Ciprofloxacin
500 mg tablet
95 - 105 17 2 481 (96.2) 506 (101.2) 0
Cotrimoxazole
400/80 mg tablet
sulfamethoxazole
trimethoprim
92.5 - 107.5
92.5 - 107.5
20 0 391 (97.8)
58 (72.5)
411 (102.8)
81 (101.3)
0
10 (50)
c
Tetracycline
250 mg capsule
95 - 105 8 10 226 (90.4) 259 (103.6) 5 (23)
d
Tetracycline
500 mg capsule
95 - 105 2 1 503 (100.6) 514 (102.8) 0
aCompared with pharmacopeial limits [23]
bTwo were obtained from a pharmacy;
cAll were obtained from a pharmacy;
dOne was obtained from a pharmacy
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gonorrhoeae has approached 100% in urban areas since
the nineties [26]. Kiosk owners used to buy their drugs
from wholesalers or drug stores. It now seems that,
because of recently tightened control of wholesalers and
drug stores, kiosk owners obtain small quantities of
antibiotics from nearby pharmacies. Strict enforcement
of the law for community pharmacies without control-
ling the kiosks might make owners turn to an alternative
illegal supply chain of anti-infectives again. Illegal
import increases the risk ofc o u n t e r f e i tp r o d u c t si n
other South East Asian countries [10,27,28]. This study
confirms the data of our previous survey [2] and state-
ments in the press [29] that Chinese traditional healers
do not retail antibiotics.
The lack of appropriate labeling and counseling in
pharmacies can be partly explained by the insufficient
level of training of pharmacy employees, which does not
include information on drugs. Other reasons for insuffi-
cient labeling and information could be the practice of
repackaging large (cheaper) packaged units, without pro-
viding (copies of) information leaflets.
The fact that eight out of nine cotrimoxazole samples
stated to be manufactured by one local company were
substandard, out of a total of ten substandard samples,
points to a production problem. Also, because no pro-
duct carried a date beyond expiration, this was consid-
ered as an unlikely cause of the low content. Although
exposure to sunlight, average high temperatures of 32°C
in Indonesia and high humidity could have led to degra-
dation of drugs in kiosks, we found no association of
substandard content of the products with the type of
medicine outlet. We cannot prove that the antibiotic
samples were produced by the companies printed on
the labels. However, we have no indication that any of
the samples were counterfeit drug products. Products
purchased in licensed pharmacies and kiosks carried the
same label and all samples contained active ingredients.
In developing countries that struggle with counterfeit
drug problems, some samples contained no active ingre-
dient at all, too high or very low amounts [8,10,30].
Using similar methods, researchers from Burma found
the antibiotic content of 21 products to be 13 to 48%
lower than expected [10]. In Laos People’sD e m o c r a t i c
Republic, ampicillin and tetracycline contained 3 to 32%
and 8 to 14% less active ingredient than expected [9]. In
the present study, apart from cotrimoxazole (maximally
20% less active ingredient), deviations from the BP2005
limits were small. As little variation in availability and
active ingredient of the antibiotics was found in the first
104 samples, this sample size was considered sufficient
for the total survey. Another recent study in Indonesia
showed a slightly lower content of rifampicin in pro-
ducts from one out of three manufacturers [16]. There-
fore, we cannot concur with former published
statements [15,17,18,21] on fraudulent drugs in Indone-
sia, although we cannot exclude that the situation has
improved recently or that the situation in Surabaya is
different from other areas in Indonesia. The regulations
seem to at least effectively guarantee the presence of
genuine antibiotics on the market.
Widespread unjustified use of the first line antibiotics
[2,31] is expected to be the major avoidable contributor to
increasing resistance. The hypotheses leading to this study
were whether active ingredient in antibiotics purchased in
the area was too low or absent. Low active ingredient
(which might contribute to the development of the resis-
tance of bacteria) was only found for cotrimoxazole
Table 4 Retail price comparison of the antibiotics
Antibiotics Recom-
mended
a
retail price
b
Actual retail price
b per capsule or tablet
median (IQR)
In pharmacies In kiosks p-value Generic Branded generic p-value
Amoxicillin
500 mg tablet
403 300
(300-400)
700
(500-1000)
0.00 500
(313-700)
Not available -
Chloramphenicol
250 mg capsule
237 258
(230-470)
875
(563-1000)
0.00 254
(224-500)
500
(460-875)
0.00
Ciprofloxacin
500 mg tablet
950 850
(500-1000)
5000
(2000-8000)
0.00 850
(500-1000)
Not available -
Cotrimoxazole
480 mg tablet
205 223
(200-405)
Not available - 220
(200-260)
850
(200-870)
0.00
Tetracycline
250 mg capsule
125 150
(150-200)
900
(800-1000)
0.00 150
(150-200)
850
(800-1000)
0.00
Tetracycline
500 mg capsule
266 350
(300-400)
750
(750-750)
0.17 350
(300-400)
750
(750-750)
0.17
a Maximum retail price set by the Minister of Health in March 2006 [25]
IQR = interquartile range
b In rupiah
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use with resistance found in the community population in
our previous survey was prior use of cotrimoxazole. It was
associated with carrying E. coli resistant to any of the
tested antibiotics (OR 5.5, 95% CI 2.1-14.8) and single tri-
methoprim/sulfamethoxazole resistance (OR 7.5, 95% CI
2.0-28.0) [3]. However, we should keep in mind that the
samples of the present study were obtained only in one
out of the two areas of the previous survey, in a different
time period and that we have no information on brand/
batches that were consumed by the individuals who car-
ried the resistant E. coli.
Prices of antibiotics with similar labels differed widely,
often exceeding the recommended [19] retail price, except
for generic amoxicillin and ciprofloxacin (Table 4). Gen-
eric products were less costly than branded products, and
prices were lower in pharmacies than in kiosks.
This is the first published report in the international
literature that provides objective information on OTC
sales and the active ingredient of frequently used oral
antibiotics in Indonesia. The strengths of the study are
the large sample size of essential antibiotics from one
stated country of origin (Indonesia) and the analysis by
a laboratory using HPLC, which is industry standard for
testing for the amount of active ingredient. Because of
the simulated client method, commonly used in similar
studies to procure drug samples for testing [8,28,30], we
were able to document real life practices. A more official
approach of drug quality assurance assessment including
drug pricing was recently developed by WHO [32].
However, this method, which also requests consent of
the responsible retailers [33], would not have exposed
the OTC sales problem.
The present study has some limitations. We were not
able to select pharmacies using random sampling
[8,10,28,30] from an official list of registered pharmacies
in Surabaya; however, our field survey approach should
exclude major bias. We assume that, because samples
and packages of the same antibiotics sold in licensed
pharmacies and kiosks looked genuine and very similar
by visual inspection and by comparison of the digital
photographs, they were not counterfeit. We did not pre-
sent the samples to the stated manufacturing companies
or to the regulatory authority, which may have more
experience and/or technology to make this determina-
tion. However, the chairman of the Indonesian Pharma-
cists Association (ISFI) recently said “ that it was
theoretically impossible for counterfeit drugs to be
taken up by hospitals or licensed pharmacies because
they normally obtained their medicines through legal
distributors”[34]. We were not systematically informed
about the expiry dates of the samples because this infor-
mation was missing for the repackaged products or
absent from the partial blister strips. However, no legi-
ble dates were beyond expiration. We selected the anti-
biotics based on their substantial usage in the area [2],
not on high cost. Therefore, we cannot generalize our
findings to all types of antibiotics, since expensive anti-
biotics might be a more interesting target for counterfei-
ters. However, large volumes of inexpensive fakes would
still provide a worthwhile profit for counterfeiters [4].
We think that our findings are relevant for the urban
areas as very similar antibiotic consumption patterns
were found in the other city of our survey on Java [2].
In addition, the stated manufacturers were Indonesian
companies from 9 different cities of Java or Sumatra
which are the main islands. Whether the results are true
for rural areas or small islands of Indonesia remains to
be seen. We analyzed two oral dosage forms only and
did not try to study liquid preparations. Our analysis in
terms of quality was limited to the content, since we did
not perform analyses of impurities or excipients which
determine the biological equivalence [24]. We did not
perform dissolution tests [35] which would assess the in
vitro availability of the drug. We did not perform follow
up experiments to determine whether the samples from
the kiosks, being exposed to heat and humidity, would
be degraded before the expiry date.
Finally, in concert with other published data from the
AMRIN study [1-3,31] that provided information on beha-
vioral, cultural and socioeconomic determinants driving
antimicrobial use and resistance on the level of the pre-
scriber and user, this study helps to fill the knowledge gap
of determinants on the level of government health policies
and the health care system in which they are implemented
in Indonesia. The World Health Organization Global
Strategy for the Containment of Antimicrobial Resistance
report [36] states that “National commitment to under-
stand and address the problem and the designation of
authority and responsibility are prerequisites for interven-
tions. Effective action requires the introduction and enfor-
cement of appropriate regulations.”
Conclusions
Despite these limitations, we conclude that OTC retail-
ing of five first-line oral antibiotics was widespread in
pharmacies and in kiosks of a major city on Java, Indo-
nesia, often at very high prices. The active ingredient
was lowest for trimethoprim in cotrimoxazole tablets,
which most likely was related to manufacturing pro-
blems. We recommend increased enforcement of exist-
ing regulations for all types of medicine outlets by the
national Drug and Food Control Agency, better training
of pharmacy personnel, control of antibiotic production
on a national level by local industries and pricing
according to WHO expert reports [32,33].
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